Safety and efficacy of tissue plasminogen activator and DNase for complicated pleural effusions secondary to abdominal pathology

Files

ACFrOgC60ciSfFyU-QySRbnhxW4kXTISCNIAbqsF8BA2ieWWLvOmNVl1-sFppRSo3MQEHF1fUwQNXvV74VaPvLnoe7G-BS96iPCDct70PygLtegY0mroRN5Ao7qXzyk=.pdf (611.66 KB)

Date

2017

Type:

Artículo

Collections

Artículos Medicina y Ciencias de la Salud

Descargas totales

48

Vistas totales

1
Gestores bibliográficos

Authors

item.contributor.advisor

ORCID:

Journal Title

Journal ISSN

Volume Title

Publisher

American Thoracic Society

item.page.isbn

item.page.issn

item.page.issne

item.page.doiurl

URI

http://hdl.handle.net/11447/1608
 http://dx.doi.org/10.1513/AnnalsATS.201608-594BC

item.page.extent

6

item.page.accessRights

item.page.other

item.page.references

Abstract

RATIONALE: Exudative pleural effusions may arise secondary to inflammation of intra-abdominal structures. Pleural space loculations can complicate these effusions, preventing adequate chest tube drai...

Description

item.page.coverage.spatial

item.page.sponsorship

Citation

Bussy S, Kheir F, Rivera E, Cheng G, Folch E. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology. Ann Am Thorac Soc. 2017 Mar;14(3):342-346. doi: 10.1513/AnnalsATS.201608-594BC.

Keywords

DNase , complicated pleural effusion , pleural effusion secondary to abdominal pathology , sympathetic pleural effusion , tissue plasminogen activator

item.page.dc.rights

item.page.dc.rights.url

Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026

Implementado por OpenGeek Services